Elite Macromolecular Synthesis & Strategic Process Development
The global frontier of medicine is rapidly shifting toward targeted therapeutic modalities, with specialized peptides leading the charge. RealP serves as a premier, end-to-end Contract Development and Manufacturing Organization (CDMO) designed to transition your proprietary sequences from early-stage discovery to high-purity, scalable production.
By combining avant-garde molecular architecture from Australia's top-tier biomedical ecosystems with robust, certified industrial infrastructure, we streamline your development timeline and provide uncompromised batch-to-batch reproducibility.
The RealP Differentiation: Global Synergy, Microscopic Precision
- Pioneering Australian Biotech Infrastructure
- Our foundational research and structural modifications are driven by distinguished biomedical authorities in Australia. Through deep-rooted alliances with premier domestic universities and biomedical hubs, we pioneer advanced modifications that optimize peptide stability, cellular penetration, and structural resilience.
- Validated Global Scale
- Mass production is handled via specialized, high-capacity GMP manufacturing facilities. This allows us to offer completely agile scaling options, moving fluidly from milligram-level high-throughput library generation to multi-kilogram commercial outputs.
- Independent U.S. Laboratory Auditing
- We do not rely solely on factory-level validation. To establish absolute empirical trust, every single batch undergoes rigid independent analysis at a trusted third-party laboratory right here in the United States. No shipment goes out without a definitive, locally verified Certificate of Analysis (CoA).
Capabilities at a glance
Pioneering Australian Biotech Infrastructure
Validated Global Scale
Independent U.S. Laboratory Auditing
Technical Architecture & Specialized Modalities
Our synthesis platforms utilize advanced chemical techniques to resolve complex sequence challenges, ensuring high-yield accuracy across all specialized formats.
Accelerated Library Generation
- Automated, parallel peptide arrays engineered for rapid structural screening and lead optimization.
- Compressed lead times to accelerate high-velocity research and discovery cycles.
- Capable of managing complex, highly extended chains stretching beyond 70 residues.
Specialized Chemistry & Structural Modifications
- Expert implementation of both Solid-Phase Peptide Synthesis (SPPS) and Liquid-Phase Peptide Synthesis (LPPS) methodologies.
- Advanced Macrocyclization: Proven expertise in stabilizing secondary structures through precise disulfide bridging (mono, di, and multi-sulfide loops), head-to-tail amide cyclization, and advanced stapled peptide architectures.
- Tailored Conjugations & Functionalization: Strategic N- and C-terminal capping, biotinylation, fluorescent tagging, PEGylation, and targeted lipid/fatty acid anchoring to dramatically extend pharmacokinetics and in vivo half-life.
Targeted Peptide-Drug Conjugates (PDCs)
- End-to-end development of bioconjugates, combining cell-penetrating or target-seeking peptide vectors with bespoke biochemical payloads via innovative, cleavable or non-cleavable linker chemistry.
Orthogonal Analytics & Rigorous Quality Management
Data integrity is the cornerstone of our operations. RealP utilizes multi-layered, ultra-precise analytical frameworks to validate every molecular parameter:
- Structural & Sequence Validation
- High-Resolution Mass Spectrometry (HRMS), tandem MS/MS fragmentation mapping, and comprehensive 1D/2D Nuclear Magnetic Resonance (NMR) spectroscopy.
- Purity & Stereochemical Assays
- Chiral purity testing and ultra-performance liquid chromatography (UPLC) profiling to trace and eliminate potential racemization or related sequence deletions.
- Compendial Release Assays
- Quantitative analysis of elemental heavy metals, residual processing solvents (volatile organic compounds), water content (Karl Fischer), bioburden, and pyrogen/endotoxin profiles.
Collaboration Modalities
We align with your operational structures through flexible, transparent engagement models:
Project-Based / Fee-For-Service (FFS)
Milestone-locked execution with transparent pricing, optimized for specific batch production, sequence validation, and scaling.
Dedicated Resource / Full-Time Equivalent (FTE)
A fully dedicated team of R&D scientists acting as a seamless extension of your internal laboratory, providing ongoing optimization, sequence alterations, and immediate project scaling.
Institutional CDMO Project Inquiry
Please provide the following technical details to initiate a feasibility review and secure a dedicated procurement consultation.